An interventional study of Mirror Therapy in Labor Anxiety, Labor Delivery and Labor, sponsored by NURTEN ÖZÇALKAP. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-01.
Sponsored by NURTEN ÖZÇALKAP · Not applicable, Interventional, and Prevention
Today, childbirth is considered one of the most physically and psychologically intense experiences in a woman's life. Labor is a critical period during which fear, anxiety, and stress related to childbirth may increase, potentially affecting both the course of labor and postpartum emotional well-being. Supportive approaches implemented during this period may contribute to a more positive perception of the childbirth experience and enhance postpartum well-being.
Mirror therapy is a non-pharmacological approach that enables individuals to visually perceive their own bodies and the ongoing process, thereby strengthening self-perception and promoting positive body awareness. The use of mirror therapy during labor may increase women's active participation in the childbirth process and enhance their sense of control. It may also support emotional well-being and reduce negative emotional states during the postpartum period.
Accordingly, this study aims to evaluate the effects of mirror therapy administered during labor on postpartum pain, mood, and emotional well-being. The findings are expected to contribute to strengthening midwifery support during childbirth, integrating non-pharmacological approaches into clinical practice, promoting their wider use, and protecting women's psychological well-being. Thus, the study is expected to provide scientific evidence that may inform midwifery education and practice as well as postpartum care policies.
423 studies on the registry are indexed under Labor Pain; 74 are open to participants now.
This study's planned enrollment of 86 is below the median of 100 across 347 interventional studies indexed under Labor Pain.
Browse Labor Pain studies →NURTEN ÖZÇALKAP is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Mirror Therapy Application
Other: Mirror Therapy
Routine Care
Mirror Therapy Application
Descriptive Information Form:
This form was developed by the researchers and includes questions regarding the participants' demographic and obstetric characteristics.
Time frame: baseline
Emotional Well-Being Scale: Baseline (before the intervention)
The Psychological Well-Being Scale was developed by Diener et al. (2010) and adapted into Turkish by Telef (2013). The scale consists of eight items within a single-factor structure and is rated on a 7-point Likert-type scale ranging from 1 to 7. The single-factor structure explains 42% of the total variance, with factor loadings ranging from .54 to .76. The Cronbach's alpha reliability coefficient of the scale was reported as .80 (Telef, 2013, p. 381).
Time frame: Baseline (before the intervention), Immediately after the intervention
Visual Analog Scale (VAS):
The Visual Analog Scale is a unidimensional instrument used to assess the participant's perceived pain intensity by converting a subjective experience into a quantitative value. The VAS consists of a 100-mm (10-cm) horizontal line, with one endpoint representing "no pain" (0) and the other representing the "worst possible pain" (10). Participants are asked to mark the point on the line that best represents the intensity of their current pain. The distance between the "no pain" endpoint and the participant's mark is measured using a ruler and recorded in centimeters, with higher scores indicating greater pain intensity. VAS scores are interpreted according to the predefined pain-intensity categories used in the study (Ergin, 2013; Aslan, 2006; Mucuk, 2009).
Time frame: Baseline (before the intervention), Immediately after the intervention
Plan to share: No
Started Aug 2026 (actual). Primary completion is estimated for Oct 2026, 2 months after the start.
Of 191 non-industry interventional studies with no phase under Labor Pain, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 14. This study's planned 2 months is below that.
Counting every sponsor, half of 193 studies reached it within 9 months; a quarter within 5 and three quarters within 14.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
NURTEN ÖZÇALKAP